BEAT

SEC source: 0001628280-24-038522 · wk-form4_1724785648.xml · nonDerivative · entry 1

de Urioste George · CIK 0001270068 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,814

F1 · ownership.direct: These shares were sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) which vested in favor of the Reporting Person on the date of the Issuer's 2024 annual meeting of stockholders, which was held on June 12, 2024.

SEC source: 0001779372-24-000014 · wk-form4_1718916414.xml · nonDerivative · entry 1

STROME MARK E · CIK 0000919484 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,146

F1 · ownership.direct: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. 100% of the RSUs shall vest on the earlier of June 12, 2025 or the date of the Issuer's 2025 annual meeting of stockholders, subject to the Reporting Person continuing to be an Outside Director (as defined in the Issuer's 2022 Equity Inventive Plan) through the applicable vesting date.

SEC source: 0001779372-24-000008 · wk-form4_1718911409.xml · nonDerivative · entry 1

Ferrari Richard · CIK 0001034413 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 149,724

F1 · ownership.direct: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. 100% of the RSUs shall vest on the earlier of June 12, 2025 or the date of the Issuer's 2025 annual meeting of stockholders, subject to the Reporting Person continuing to be an Outside Director (as defined in the Issuer's 2022 Equity Inventive Plan) through the applicable vesting date.

SEC source: 0001779372-24-000007 · wk-form4_1718911239.xml · nonDerivative · entry 2

Ortigas-Wedekind Marga · CIK 0001453971 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 112,293

F2 · ownership.direct: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. 100% of the RSUs shall vest on the earlier of June 12, 2025, or the date of the Issuer's 2025 annual meeting of stockholders, subject to the Reporting Person continuing to be an Outside Director (as defined in the Issuer's 2022 Equity Inventive Plan) through the applicable vesting date.

SEC source: 0001779372-24-000011 · wk-form4_1718911653.xml · nonDerivative · entry 1

de Urioste George · CIK 0001270068 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 69,314

F1 · ownership.direct: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. 100% of the RSUs shall vest on the earlier of June 12, 2025, or the date of the Issuer's 2025 annual meeting of stockholders, subject to the Reporting Person continuing to be an Outside Director (as defined in the Issuer's 2022 Equity Inventive Plan) through the applicable vesting date.

SEC source: 0001779372-24-000017 · wk-form4_1718917969.xml · nonDerivative · entry 1

Nelson Kenneth Warwick III · CIK 0001981293 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 127,147

F1 · ownership.direct: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. 100% of the RSUs shall vest on the earlier of June 12, 2025 or the date of the Issuer's 2025 annual meeting of stockholders, subject to the Reporting Person continuing to be an Outside Director (as defined in the Issuer's 2022 Equity Inventive Plan) through the applicable vesting date.

SEC source: 0001779372-24-000016 · wk-form4_1718917090.xml · nonDerivative · entry 1

JAFF MICHAEL R · CIK 0001988352 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,120

F1 · ownership.direct: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. 100% of the RSUs shall vest on the earlier of June 12, 2025, or the date of the Issuer's 2025 annual meeting of stockholders, subject to the Reporting Person continuing to be an Outside Director (as defined in the Issuer's 2022 Equity Inventive Plan) through the applicable vesting date.

SEC source: 0001779372-24-000015 · wk-form4_1718916634.xml · nonDerivative · entry 1

Elfrink Willem · CIK 0001893194 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 317,982

F1 · ownership.direct: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. 100% of the RSUs shall vest on the earlier of June 12, 2025, or the date of the Issuer's 2025 annual meeting of stockholders, subject to the Reporting Person continuing to be an Outside Director (as defined in the Issuer's 2022 Equity Inventive Plan) through the applicable vesting date.

SEC source: 0001779372-23-000033 · wk-form4_1696375072.xml · nonDerivative · entry 1

de Urioste George · CIK 0001270068 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,129

F1 · shares: These shares were sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) which vested in favor of the Reporting Person on the date of the Issuer's 2023 annual meeting of stockholders, which was held on July 7, 2023. The RSUs vested during a blackout period causing a delay in the sale of shares.

SEC source: 0001779372-23-000031 · wk-form4_1696030856.xml · nonDerivative · entry 2

de Urioste George · CIK 0001270068 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,629

F1 · shares: These shares were sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) which vested in favor of the Reporting Person on the date of the Issuer's 2023 annual meeting of stockholders, which was held on July 7, 2023. The RSUs vested during a blackout period causing a delay in the sale of shares.

SEC source: 0001779372-23-000031 · wk-form4_1696030856.xml · nonDerivative · entry 1

de Urioste George · CIK 0001270068 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,629

F1 · shares: These shares were sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) which vested in favor of the Reporting Person on the date of the Issuer's 2023 annual meeting of stockholders, which was held on July 7, 2023. The RSUs vested during a blackout period causing a delay in the sale of shares.

SEC source: 0001779372-23-000029 · wk-form4_1695830472.xml · nonDerivative · entry 2

de Urioste George · CIK 0001270068 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,463

F1 · shares: These shares were sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) which vested in favor of the Reporting Person on the date of the Issuer's 2023 annual meeting of stockholders, which was held on July 7, 2023. The RSUs vested during a blackout period causing a delay in the sale of shares.

SEC source: 0001779372-23-000029 · wk-form4_1695830472.xml · nonDerivative · entry 1

de Urioste George · CIK 0001270068 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,463

F1 · shares: These shares were sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) which vested in favor of the Reporting Person on the date of the Issuer's 2023 annual meeting of stockholders, which was held on July 7, 2023. The RSUs vested during a blackout period causing a delay in the sale of shares.

SEC source: 0001779372-23-000027 · wk-form4_1695424023.xml · nonDerivative · entry 2

de Urioste George · CIK 0001270068 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,856

F1 · shares: These shares were sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) which vested in favor of the Reporting Person on the date of the Issuer's 2023 annual meeting of stockholders, which was held on July 7, 2023. The RSUs vested during a blackout period causing a delay in the sale of shares.

SEC source: 0001779372-23-000027 · wk-form4_1695424023.xml · nonDerivative · entry 1

de Urioste George · CIK 0001270068 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,956

F1 · shares: These shares were sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) which vested in favor of the Reporting Person on the date of the Issuer's 2023 annual meeting of stockholders, which was held on July 7, 2023. The RSUs vested during a blackout period causing a delay in the sale of shares.

SEC source: 0001779372-23-000024 · wk-form4_1695163870.xml · nonDerivative · entry 2

de Urioste George · CIK 0001270068 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,839

F1 · shares: These shares were sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) which vested in favor of the Reporting Person on the date of the Issuer's 2023 annual meeting of stockholders, which was held on July 7, 2023. The RSUs vested during a blackout period causing a delay in the sale of shares.

SEC source: 0001779372-23-000024 · wk-form4_1695163870.xml · nonDerivative · entry 1

de Urioste George · CIK 0001270068 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 64,839

F1 · shares: These shares were sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) which vested in favor of the Reporting Person on the date of the Issuer's 2023 annual meeting of stockholders, which was held on July 7, 2023. The RSUs vested during a blackout period causing a delay in the sale of shares.

SEC source: 0001779372-23-000022 · wk-form4_1694813790.xml · nonDerivative · entry 3

de Urioste George · CIK 0001270068 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 69,108

F1 · shares: 1. These shares were sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) which vested in favor of the Reporting Person on the date of the Issuer's 2023 annual meeting of stockholders, which was held on July 7, 2023. The RSUs vested during a blackout period causing a delay in the sale of shares.

SEC source: 0001779372-23-000022 · wk-form4_1694813790.xml · nonDerivative · entry 2

de Urioste George · CIK 0001270068 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 74,108

F1 · shares: 1. These shares were sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) which vested in favor of the Reporting Person on the date of the Issuer's 2023 annual meeting of stockholders, which was held on July 7, 2023. The RSUs vested during a blackout period causing a delay in the sale of shares.

SEC source: 0001779372-23-000022 · wk-form4_1694813790.xml · nonDerivative · entry 1

de Urioste George · CIK 0001270068 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 77,230

F1 · shares: 1. These shares were sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) which vested in favor of the Reporting Person on the date of the Issuer's 2023 annual meeting of stockholders, which was held on July 7, 2023. The RSUs vested during a blackout period causing a delay in the sale of shares.

SEC source: 0001213900-23-063798 · ownership.xml · derivative · entry 1

Persen Kenneth Harry · CIK 0001942350 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 421,000

Underlying: Common Stock · 252,000 shares

Expires 2033-08-02

F1 · shares: The options ("Option" and collectively, "Options") have been issued from the Company's 2022 Equity Incentive Plan, that was approved by the Members of the Board of Directors on August 1, 2023.

F2 · derivative.exercise_date: The Options will vest and become exercisable with respect to 40% of the shares starting August 1, 2023, with one forty-eighth (1/48th) of the shares vesting each calendar month thereafter on the same day of the month as the first vesting date. The remaining 60% of the shares will vest and become exercisable once HeartBeam, Inc. receives FDA Clearance for marketing of HeartBeam's synthesized 12-Lead product obtained by signal synthesis from the recorded xyz signals.

SEC source: 0001213900-23-063797 · ownership.xml · derivative · entry 1

Vajdic Branislav · CIK 0001422425 · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,194,000

Underlying: Common Stock · 796,000 shares

Expires 2033-08-02

F1 · shares: The options ("Option" and collectively, "Options") have been issued from the Company's 2022 Equity Incentive Plan, that was approved by the Members of the Board of Directors on August 1, 2023.

F2 · derivative.exercise_date: The Options will vest and become exercisable with respect to 40% of the shares starting August 1, 2023, with one forty-eighth (1/48th) of the shares vesting each calendar month thereafter on the same day of the month as the first vesting date. The remaining 60% of the shares will vest and become exercisable once HeartBeam, Inc. receives FDA Clearance for marketing of HeartBeam's synthesized 12-Lead product obtained by signal synthesis from the recorded xyz signals.

SEC source: 0001213900-23-063795 · ownership.xml · derivative · entry 1

ENO Robert Paul · CIK 0001963418 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 536,000

Underlying: Common Stock · 357,000 shares

Expires 2033-08-02

F1 · shares: The options ("Option" and collectively, "Options") have been issued from the Company's 2022 Equity Incentive Plan, that was approved by the Members of the Board of Directors on August 1, 2023.

F2 · derivative.exercise_date: The Options will vest and become exercisable with respect to 40% of the shares starting August 1, 2023, with one forty-eighth (1/48th) of the shares vesting each calendar month thereafter on the same day of the month as the first vesting date. The remaining 60% of the shares will vest and become exercisable once HeartBeam, Inc. receives FDA Clearance for marketing of HeartBeam's synthesized 12-Lead product obtained by signal synthesis from the recorded xyz signals.

SEC source: 0001213900-23-057565 · ownership.xml · nonDerivative · entry 1

Ortigas-Wedekind Marga · CIK 0001453971 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 79,108

F1 · shares: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. 100% of the RSUs shall vest on the earlier of July 13, 2024 or the date of the Issuer's 2024 annual meeting of stockholders, subject to the Reporting Person continuing to be an Outside Director (as defined in the Issuer's 2022 Equity Inventive Plan) through the applicable vesting date.

SEC source: 0001213900-23-057564 · ownership.xml · nonDerivative · entry 1

de Urioste George · CIK 0001270068 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 79,108

F1 · shares: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. 100% of the RSUs shall vest on the earlier of July 13, 2024 or the date of the Issuer's 2024 annual meeting of stockholders, subject to the Reporting Person continuing to be an Outside Director (as defined in the Issuer's 2022 Equity Inventive Plan) through the applicable vesting date.

SEC source: 0001213900-23-057567 · ownership.xml · nonDerivative · entry 1

Nelson Kenneth Warwick III · CIK 0001981293 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 93,962

F1 · shares: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. 100% of the RSUs shall vest on the earlier of July 13, 2024 or the date of the Issuer's 2024 annual meeting of stockholders, subject to the Reporting Person continuing to be an Outside Director (as defined in the Issuer's 2022 Equity Inventive Plan) through the applicable vesting date.

SEC source: 0001213900-23-057633 · ownership.xml · nonDerivative · entry 1

STROME MARK E · CIK 0000919484 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,961

F1 · shares: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. 100% of the RSUs shall vest on the earlier of July 13, 2024 or the date of the Issuer's 2024 annual meeting of stockholders, subject to the Reporting Person continuing to be an Outside Director (as defined in the Issuer's 2022 Equity Inventive Plan) through the applicable vesting date.

SEC source: 0001213900-23-057632 · ownership.xml · nonDerivative · entry 1

Ferrari Richard · CIK 0001034413 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 105,477

F1 · shares: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. 100% of the RSUs shall vest on the earlier of July 13, 2024 or the date of the Issuer's 2024 annual meeting of stockholders, subject to the Reporting Person continuing to be an Outside Director (as defined in the Issuer's 2022 Equity Inventive Plan) through the applicable vesting date.

SEC source: 0001213900-23-057979 · ownership.xml · nonDerivative · entry 1

Elfrink Willem · CIK 0001893194 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 284,797

F1 · shares: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. 100% of the RSUs shall vest on the earlier of July 13, 2024 or the date of the Issuer's 2024 annual meeting of stockholders, subject to the Reporting Person continuing to be an Outside Director (as defined in the Issuer's 2022 Equity Inventive Plan) through the applicable vesting date.

F2 · balance_after: The number of shares owned by this Reporting Person have been adjusted to correct cumulative errors in prior beneficial ownership reports. These errors stem from: (1) Form 3 filed on November 12, 2021 which should have reported beneficial ownership of 101,818 shares of common stock directly owned; (2) Form 4 filed on November 15, 2021 which incorrectly added direct ownership and indirect ownership, and (3) Form 4 filed on February 13, 2023, which incorrectly disclosed the disposition of 125,351 of 164,610 shares held by WPE Ventures Partnership. These shares were held by WPE Ventures Partnership, of which the Reporting Person was the managing partner. The remaining 39,259 shares held by WPE Ventures Partnership, of which the Reporting Person was the managing partner, was transferred to Mr. Willem Elfrink directly.

SEC source: 0001779372-23-000017 · wk-form4_1686355142.xml · derivative · entry 1

Persen Kenneth Harry · CIK 0001942350 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 169,000

Underlying: Common Stock · 169,000 shares

Expires 2033-05-13

F1 · derivative.exercise_price: The exercise price per share of each option (?Option? and collectively, the ?Options?) shall be the Fair Market Value (as defined in the Company?s 2022 Equity Incentive Plan) of a share as of May 14, 2023.

F2 · shares: The Options have been issued from the Company's 2022 Equity Incentive Plan, that was approved by the Members of the Board of Directors on May 14, 2023.

F3 · derivative.exercise_date: The Options will vest and become exercisable with respect to 40% of the shares starting May 14, 2023, with one forty-eighth (1/48th) of the shares vesting each calendar month thereafter on the same day of the month as the first vesting date. The remaining 60% of the shares will vest and become exercisable once HeartBeam, Inc. receives FDA Clearance for marketing of HeartBeam?s synthesized 12-Lead product obtained by signal synthesis from the recorded xyz signals.

SEC source: 0001779372-23-000016 · wk-form4_1686355035.xml · derivative · entry 1

Vajdic Branislav · CIK 0001422425 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 398,000

Underlying: Common Stock · 398,000 shares

Expires 2033-05-13

F1 · derivative.exercise_price: The exercise price per share of each option (?Option? and collectively, the ?Options?) shall be the Fair Market Value (as defined in the Company?s 2022 Equity Incentive Plan) of a share as .

F2 · shares: The Options have been issued from the Company's 2022 Equity Incentive Plan, that was approved by the Members of the Board of Directors on May 14, 2023.

F3 · derivative.exercise_date: The Options will vest and become exercisable with respect to 40% of the shares starting May 14, 2023, with one forty-eighth (1/48th) of the shares vesting each calendar month thereafter on the same day of the month as the first vesting date. The remaining 60% of the shares will vest and become exercisable once HeartBeam, Inc. receives FDA Clearance for marketing of HeartBeam?s synthesized 12-Lead product obtained by signal synthesis from the recorded xyz signals.

SEC source: 0001779372-23-000018 · wk-form4_1686355324.xml · derivative · entry 1

ENO Robert Paul · CIK 0001963418 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 179,000

Underlying: Common Stock · 179,000 shares

Expires 2033-05-13

F1 · derivative.exercise_price: The exercise price per share of each option (?Option? and collectively, the ?Options?) shall be the Fair Market Value (as defined in the Company?s 2022 Equity Incentive Plan) of a share as of May 14, 2023.

F2 · shares: The Options have been issued from the Company's 2022 Equity Incentive Plan, that was approved by the Members of the Board of Directors on May 14, 2023.

F3 · derivative.exercise_date: The Options will vest and become exercisable with respect to 40% of the shares starting May 14, 2023, with one forty-eighth (1/48th) of the shares vesting each calendar month thereafter on the same day of the month as the first vesting date. The remaining 60% of the shares will vest and become exercisable once HeartBeam, Inc. receives FDA Clearance for marketing of HeartBeam?s synthesized 12-Lead product obtained by signal synthesis from the recorded xyz signals.

SEC source: 0001779372-23-000008 · wf-form4_167961771712287.xml · derivative · entry 1

Persen Kenneth Harry · CIK 0001942350 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Common Stock · 60,000 shares

Expires 2033-03-21

F1 · shares: The options ("Options") have been issued from the Company's 2022 Equity Incentive Plan, that was approved by the Members of the Board of Directors on March 21, 2023.

F2 · derivative.exercise_date: The Option will vest and become exercisable with respect to 25% of the shares starting March 21, 2024 and one forty-eighth (1/48th) of the shares shall vest each calendar month thereafter on the same day of the month as the first vesting date.

SEC source: 0001213900-23-011778 · ownership.xml · derivative · entry 1

Elfrink Willem · CIK 0001893194 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 43,636 shares

Expires 2023-02-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001213900-23-011777 · ownership.xml · derivative · entry 2

Vajdic Branislav · CIK 0001422425 · CHIEF EXECUTIVE OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 728

Underlying: Common Stock · 5,090 shares

Expires 2023-02-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Cashless exercise of common stock warrant

SEC source: 0001213900-23-011777 · ownership.xml · nonDerivative · entry 1

Vajdic Branislav · CIK 0001422425 · CHIEF EXECUTIVE OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 911,391

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Cashless exercise of common stock warrant

SEC source: 0001213900-23-011776 · ownership.xml · derivative · entry 2

Brounstein Richard · CIK 0001189694 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 728

Underlying: Common Stock · 727 shares

Expires 2023-02-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Cashless exercise of common stock warrant

SEC source: 0001213900-23-011776 · ownership.xml · nonDerivative · entry 1

Brounstein Richard · CIK 0001189694 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 112,108

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Cashless exercise of common stock warrant

SEC source: 0001213900-23-010991 · ownership.xml · derivative · entry 3

Elfrink Willem · CIK 0001893194 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,640 shares

Expires 2023-02-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001213900-23-010991 · ownership.xml · nonDerivative · entry 2

Elfrink Willem · CIK 0001893194 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 316,150

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001213900-23-010991 · ownership.xml · nonDerivative · entry 1

Elfrink Willem · CIK 0001893194 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 312,510

SEC source: 0001779372-22-000049 · wf-form4_167001571657815.xml · derivative · entry 2

Brounstein Richard · CIK 0001189694 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 760 shares

Expires 2029-01-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001779372-22-000049 · wf-form4_167001571657815.xml · nonDerivative · entry 1

Brounstein Richard · CIK 0001189694 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 111,924

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001779372-22-000046 · wf-form4_166742036420449.xml · derivative · entry 2

Brounstein Richard · CIK 0001189694 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 760

Underlying: Common Stock · 759 shares

Expires 2029-01-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001779372-22-000046 · wf-form4_166742036420449.xml · nonDerivative · entry 1

Brounstein Richard · CIK 0001189694 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 111,164

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001779372-22-000042 · wf-form4_166483131724642.xml · derivative · entry 2

Brounstein Richard · CIK 0001189694 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,519

Underlying: Common Stock · 760 shares

Expires 2029-01-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001779372-22-000042 · wf-form4_166483131724642.xml · nonDerivative · entry 1

Brounstein Richard · CIK 0001189694 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 110,405

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001779372-22-000043 · wf-form4_166517804228881.xml · derivative · entry 1

Persen Kenneth Harry · CIK 0001942350 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock · 80,000 shares

Expires 2032-09-16

F1 · shares: The options ("Options") have been issued from the Company's 2022 Equity Incentive Plan, that was approved by the Members of the Board of Directors on September 16, 2022.

F2 · derivative.exercise_date: The Option will vest and become exercisable with respect to 25% of the shares starting August 2, 2023 and one forty-eighth (1/48th) of the shares shall vest each calendar month thereafter on the same day of the month as the first vesting date. All Options shall accelerate and vest in full upon the Company's termination of the Reporting Person's engagement with the Company following a change in control.

SEC source: 0001779372-22-000038 · wf-form4_166215334403965.xml · derivative · entry 2

Brounstein Richard · CIK 0001189694 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,279

Underlying: Common Stock · 757 shares

Expires 2029-01-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001779372-22-000038 · wf-form4_166215334403965.xml · nonDerivative · entry 1

Brounstein Richard · CIK 0001189694 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 109,645

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.